19 Apr 2010
(MENAFN) The Chairman of the Qatar German Company for Medical Devices (QGMD) said that the company is all set to enter Brazilian market with its safety syringes, while at the same time it is seeking entry into the US market, Gulf Times reported.
QGMD, specialized in manufacturing high standard injection products such as sterile intravenous cannula, conventional single use syringes, needles, catheters and dialysis kits and blood bags, reported a 74 percent dip in net profit last year despite more than doubled sales.
He said that approval from the US Food and Drug Administration (FDA) is still pending although the company complied with equally accredited European standards.
Export-oriented QGMD already supplies 16 countries, including the six GCC countries, Europe, Russia, Ukraine, Greece, Mexico, Palestine, South Africa, Turkey, Sudan, Egypt, Libya, Iran and Iraq.
The company had entered into a long term supply contract for a period of five year with Siegfried Schumacher regarding the distribution of more than 100 million disposable medical devices such as intravenous catheters, traditional syringes and safety syringes.
13 Aug 2025
BBK’s BD 5,000,000 Al Hayrat scheme awards BD 680,000 to 390 Al Hayrat winners in August and September
04 Aug 2025
HM the King’s Support for Youth is an Inspirational Model for Their Empowerment Journey
28 Jul 2025
BBK discloses its financial results for the half year ended 30th June 2025
20 Jul 2025
CBB approves the transfer of the retail banking operations of HSBC Bank Middle East, Bahrain Branch to BBK
08 Jul 2025
BBK proudly launches the third edition of “Grow” and welcomes 20 Bahraini graduates
03 Jul 2025
BBK hosts executive leadership session on digital assets in collaboration with Rain
02 Jul 2025
BBK launches the largest-ever Al Hayrat Prizes, offering BD 5 million to over 2,000 winners
16 Jun 2025
BBK and CrediMax Offer Exclusive 20% Discount on Turkish Airlines Flights for Cardholders
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more